Evidence map›Paper›PMID 32430068›Full record

ArticleDiagnostic pathology2020

Gli1 regulates stemness characteristics in gastric adenocarcinoma.

Wenbo Qi, Zhaoting Yang, Ying Feng, Haoyue Li, Nan Che, Lan Liu, Yanhua Xuan

Open access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Wenbo QiInstitute for Regenerative Medicine, Yanbian University College of Medicine, Yanji, China.
Zhaoting YangInstitute for Regenerative Medicine, Yanbian University College of Medicine, Yanji, China.
Ying FengInstitute for Regenerative Medicine, Yanbian University College of Medicine, Yanji, China.
Haoyue LiInstitute for Regenerative Medicine, Yanbian University College of Medicine, Yanji, China.
Nan CheInstitute for Regenerative Medicine, Yanbian University College of Medicine, Yanji, China.
Lan LiuDepartment of Pathology, Affiliated Hospital of Yanbian University, Yanji, China. lliu@ybu.edu.cn.
Yanhua XuanInstitute for Regenerative Medicine, Yanbian University College of Medicine, Yanji, China. xuanyh1@ybu.edu.cn.
Yanbian University · CNLanzhou University Second Hospital · CNYanbian University Hospital · CN

Funding

National Natural Science Foundation of China 31760330National Natural Science Foundation of China 31860321National Natural Science Foundation of China 81760531
6 · The paper itself

Abstract

backgroundGlioma-associated oncogene homolog 1 (Gli1), affects the progression and the stemness characteristics of malignant carcinoma. The aim of the present study was to identify the relation between Glioma-associated oncogene homolog 1 (Gli1) and stemness and determine its clinical significance in gastric adenocarcinoma (GA). We investigated Gli1 expression and its correlation with other stemness-associated proteins in 169 GA samples and 5 GA cell lines.

methodsTo elucidate the role of Gli1 in the clinicopathological significance and stemness of GA, tissues samples from 169 GA patients were collected for immunohistochemistry (IHC). Additionally, MKN74, MKN28, NCI-N87, SNU638, AGS cells were collected for western blotting, MKN28 cells were collected for spheroid formation assay.

resultsResults showed that Gli1 expression was closely related to tumor grade, primary tumor (pT) stage, distant metastasis, clinical stage, gross type, microvessel density, and shorter overall survival (OS). Cox regression analysis verified that Gli1 was an independent prognostic factor for OS. Furthermore, Gli1 expression correlated with the expression of stemness-related genes, CD44, LSD1, and Sox9. Gli1 inhibitor GANT61 significantly decreased the expression of CD44 and LSD1, and spheroid formation ability of the MKN28 cells.

conclusionsIn conclusion, Gli1 may be a poor prognostic indicator and a potential cancer stemness-related protein in GA.

Indexed as

AdenocarcinomaAgedBiomarkers, TumorFemaleHumansMaleMiddle AgedNeoplastic Stem CellsPrognosisStomach NeoplasmsZinc Finger Protein GLI1Biomarkers, TumorGLI1 protein, humanZinc Finger Protein GLI1Cancer stemnessGastric adenocarcinomaGlioma-associated oncogene homolog 1Prognosis

Identifiers

PMID32430068
PMCPMC7236965
OpenAlexW3027059632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.